UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Genexine sets up joint firm in Thailand
by Lee Han-soo
2019-09-26 17:00
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
by Lee Han-soo
2019-09-26 15:39
Pfizer’s leukemia therapy Besponsa to get insurance benefit
by Kim Yun-mi
2019-09-26 11:26
'Xtandi emerges as convenient treatment option for prostate cancer patients'
by Lee Han-soo
2019-09-25 17:39
Huons, Lipac Oncology to co-develop bladder cancer treatment
by Lee Han-soo
2019-09-25 11:18
라인
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
by Lee Han-soo
2019-09-24 18:08
Qurient enrolls patients for trials of atopy treatment
by Lee Han-soo
2019-09-24 17:00
Hanmi’s US partner to unveil results of anticancer drug study
by Lee Han-soo
2019-09-24 17:00
Why using end-to-end services should be part of a drug product strategy
by Lee Han-soo
2019-09-24 16:54
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment
by Lee Han-soo
2019-09-24 16:38
라인
Hwail, SupexBNP wins patent for neutropenia treatment in US
by Lee Han-soo
2019-09-23 22:34
Drug firms uncertain about pricing of quadrivalent flu vaccines
by Jeong Sae-im
2019-09-23 14:52
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC
by Lee Han-soo
2019-09-23 13:28
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’
by Kim Yun-mi
2019-09-23 11:45
‘Daewoong’s diabetes therapy proves superior blood-sugar-lowering effect to existing drugs’
by Lee Han-soo
2019-09-20 17:51
라인
Dongwha could lose ₩60 billion sales as GSK ends deal
by Lee Han-soo
2019-09-20 14:28
Novo Nordisk releases trial result for basal insulin analog injection
by Lee Han-soo
2019-09-20 12:27
Multinational pharmaceuticals continue to increase R&D spending in Korea
by Lee Han-soo
2019-09-19 17:15
Hanmi unveils strong diabetes pipeline at EU meet
by Lee Han-soo
2019-09-19 15:30
‘Galderma Korea ran background checks on unionized workers’
by Jeong Sae-im
2019-09-19 15:18
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top